{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T17:06:04Z","timestamp":1792256764134,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.vaccine.2010.10.016","type":"journal-article","created":{"date-parts":[[2010,10,23]],"date-time":"2010-10-23T08:18:39Z","timestamp":1287821919000},"page":"58-64","source":"Crossref","is-referenced-by-count":25,"title":["Adverse event reports following Japanese encephalitis vaccination in the United States, 1999\u20132009"],"prefix":"10.1016","volume":"29","author":[{"given":"Nicole P.","family":"Lindsey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Erin","family":"Staples","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Sejvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Griggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Iskander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine R.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.10.016_bib0005","series-title":"Health information for international travel 2010","first-page":"74","article-title":"Japanese encephalitis","author":"Fischer","year":"2009"},{"issue":"1","key":"10.1016\/j.vaccine.2010.10.016_bib0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.idc.2004.11.004","article-title":"Cetron MS. Yellow fever and Japanese encephalitis vaccines: indications and complications","volume":"19","author":"Marfin","year":"2005","journal-title":"Infect Dis Clin North Am"},{"issue":"2","key":"10.1016\/j.vaccine.2010.10.016_bib0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1086\/341247","article-title":"Japanese encephalitis vaccine for travelers: exploring the limits of risk","volume":"35","author":"Shlim","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"RR-1","key":"10.1016\/j.vaccine.2010.10.016_bib0020","first-page":"1","article-title":"Japanese encephalitis vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"CDC","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"RR-1","key":"10.1016\/j.vaccine.2010.10.016_bib0025","first-page":"1","article-title":"Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"42","author":"CDC","year":"1993","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2010.10.016_bib0030","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/infdis\/161.5.878","article-title":"Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants","volume":"161","author":"Poland","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.10.016_bib0035","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4269\/ajtmh.1999.61.288","article-title":"Japanese encephalitis vaccine (inactivated BIKEN) in US soldiers: immunogenicity and safety of vaccine administered in two dosing regimens","volume":"61","author":"Defraites","year":"1999","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2010.10.016_bib0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0887-8994(92)90036-X","article-title":"Acute disseminated encephalomyelitis after Japanese B encephalitis vaccination","volume":"8","author":"Ohtaki","year":"1992","journal-title":"Pediatr Neurol"},{"issue":"11","key":"10.1016\/j.vaccine.2010.10.016_bib0045","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0264-410X(97)00020-0","article-title":"Allergic mucocutaneous reactions to Japanese encephalitis vaccine","volume":"15","author":"Plesner","year":"1997","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2010.10.016_bib0050","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1468-1331.1998.550479.x","article-title":"Neurological complications to vaccination against Japanese encephalitis","volume":"5","author":"Plesner","year":"1998","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.vaccine.2010.10.016_bib0055","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0889-8561(03)00102-4","article-title":"Allergic reactions to Japanese encephalitis vaccine","volume":"23","author":"Plesner","year":"2003","journal-title":"Immunol Allergy Clin North Am"},{"issue":"26","key":"10.1016\/j.vaccine.2010.10.016_bib0060","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1016\/S0264-410X(00)00111-0","article-title":"Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. The VAERS working group","volume":"18","author":"Takahashi","year":"2000","journal-title":"Vaccine"},{"issue":"8748","key":"10.1016\/j.vaccine.2010.10.016_bib0065","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/0140-6736(91)92707-9","article-title":"Side-effects with Japanese encephalitis vaccine","volume":"337","author":"Andersen","year":"1991","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2010.10.016_bib0070","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/clinids\/24.2.265","article-title":"Systemic reactions in US marine corps personnel who received Japanese encephalitis vaccine","volume":"24","author":"Berg","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"8962","key":"10.1016\/j.vaccine.2010.10.016_bib0075","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0140-6736(95)92636-4","article-title":"Immunisation against Japanese encephalitis","volume":"345","author":"Bonington","year":"1995","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.vaccine.2010.10.016_bib0080","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/0264-410X(94)90274-7","article-title":"Systemic allergic reactions to Japanese encephalitis vaccines","volume":"12","author":"Nazareth","year":"1994","journal-title":"Vaccine"},{"issue":"8771","key":"10.1016\/j.vaccine.2010.10.016_bib0085","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0140-6736(91)91531-X","article-title":"Adverse reactions to Japanese encephalitis vaccine","volume":"338","author":"Ruff","year":"1991","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2010.10.016_bib0090","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3928\/0090-4481-20040901-11","article-title":"The role of the Vaccine Adverse Event Reporting System (VAERS) in monitoring vaccine safety","volume":"33","author":"Iskander","year":"2004","journal-title":"Pediatr Ann"},{"issue":"4","key":"10.1016\/j.vaccine.2010.10.016_bib0095","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00006454-200404000-00002","article-title":"Understanding vaccine safety information from the Vaccine Adverse Event Reporting System","volume":"23","author":"Varricchio","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2010.10.016_bib0100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","article-title":"The medical dictionary for regulatory activities (MedDRA)","volume":"20","author":"Brown","year":"1999","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2010.10.016_bib0105","unstructured":"21CFR600.80 (Code of Federal Regulations, Title 21, Part 600, Sec. 600.80). Postmarketing reporting of adverse experiences. Available at http:\/\/edocket.access.gpo.gov\/cfr_2010\/aprqtr\/pdf\/21cfr600.80.pdf."},{"issue":"31","key":"10.1016\/j.vaccine.2010.10.016_bib0110","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"25","author":"Ruggeberg","year":"2007","journal-title":"Vaccine"},{"issue":"June","key":"10.1016\/j.vaccine.2010.10.016_bib0115","article-title":"Guillain-Barr\u00e9 Syndrome and Fisher Syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","author":"Sejvar","year":"2010","journal-title":"Vaccine"},{"issue":"31","key":"10.1016\/j.vaccine.2010.10.016_bib0120","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1016\/j.vaccine.2007.04.060","article-title":"Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"25","author":"Sejvar","year":"2007","journal-title":"Vaccine"},{"issue":"31","key":"10.1016\/j.vaccine.2010.10.016_bib0125","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1016\/j.vaccine.2007.04.058","article-title":"Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data","volume":"25","author":"Tapiainen","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2010.10.016_bib0130","first-page":"80","article-title":"Nonimmediate allergic reactions induced by drugs: pathogenesis and diagnostic tests","volume":"19","author":"Torres","year":"2009","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.vaccine.2010.10.016_bib0135","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.iac.2009.04.005","article-title":"Approach to the patient with drug allergy","volume":"29","author":"Schnyder","year":"2009","journal-title":"Immunol Allergy Clin N Am"},{"issue":"1","key":"10.1016\/j.vaccine.2010.10.016_bib0140","first-page":"1","article-title":"Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)\u2013United States, 1991\u20132001","volume":"52","author":"Zhou","year":"2003","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.vaccine.2010.10.016_bib0145","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/milmed\/164.2.157","article-title":"Sudden death after typhoid and Japanese encephalitis vaccination in a young male taking pseudoephedrine","volume":"184","author":"Franklin","year":"1999","journal-title":"Military Med"},{"key":"10.1016\/j.vaccine.2010.10.016_bib0150","series-title":"Infectious disease surveillance","first-page":"241","article-title":"Public health surveillance for vaccine adverse events","author":"Iskander","year":"2007"},{"issue":"21","key":"10.1016\/j.vaccine.2010.10.016_bib0155","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1016\/j.vaccine.2007.02.075","article-title":"Safety review of the purified chick embryo cell rabies vaccine: data from the Vaccine Adverse Event Reporting System (VAERS), 1997\u20132005","volume":"25","author":"Dobardzic","year":"2007","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2010.10.016_bib0160","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1086\/381548","article-title":"Postmarketing safety surveillance for typhoid fever vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002","volume":"38","author":"Begier","year":"2004","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10014854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10014854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T20:29:40Z","timestamp":1559766580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10014854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0264410X10014854"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.10.016","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}